Integrated Proteomics and Metabolomics Reveal the Direct Hepatic Protection of Propionate Against Alcoholic Liver Disease via the RGN-PPARα Pathway
Nutrients · 09.03.2026 · 18 (5) · 872
DOI: 10.3390/nu18050872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 09.03.2026. Verfasst von Haidi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Shand…. Hauptthemen laut MEDLINE: PPAR alpha, Proteomics, Liver Diseases, Alcoholic, Metabolomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Science, Education and Industry Integration Innovation Pilot Project from Qilu University of Technology.
Abstract (Originalsprache)
Background
Propionate, a gut microbiota-derived metabolite, has previously been shown to alleviate chronic alcoholic liver disease (ALD) by preserving intestinal barrier integrity. However, its direct hepatoprotective mechanisms remain unclear.
Methods
In this study, employing an acute ALD model to minimize the interference from gut–liver axis effects, we investigated the direct hepatic protection of propionate.
Results
Our results demonstrated that propionate administration significantly attenuated hepatic steatosis and oxidative stress. Consistently, in EtOH/OA (oleic acid)-exposed AML-12 hepatocytes, propionate enhanced cell viability and reduced lipid accumulation. Integrated proteomic and metabolomic analyses revealed that propionate altered hepatic proteins and metabolites profiles to stimulate lipolysis, promote fatty acid oxidation, and strengthen antioxidant defenses, consequently restoring lipid homeostasis in ALD mice. Mechanistically, we identified that these beneficial effects may be driven by the upregulation of regucalcin (RGN) following propionate treatments, which, in turn, may activate downstream PPARα signaling via increased levels of p-AMPK, PPARα, ACOX1 and CPT1A.
Conclusions
These findings provide novel insight into the liver-centric mechanism through which propionate ameliorates ALD and further support its therapeutic potential in ALD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Shandong Analysis and Test Center, Qilu University of Technology (Shandong…
- Shandong Shanwei ImmunoTech Co., Ltd., Jinan 250014, China.
ORCID-Profile: Yan Mu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Science, Education and Industry Integration Innovation Pilot Project from Qilu University of Technology
- Talent Project of Shandong Province
Zitieren
APA
Wang, H., Liu, H., Wang, M., Chi, T., Liu, F., Qu, X., Mu, Y., Xu, Q., & Wang, Q. (2026). Integrated Proteomics and Metabolomics Reveal the Direct Hepatic Protection of Propionate Against Alcoholic Liver Disease via the RGN-PPARα Pathway. Nutrients, 18(5), 872. https://doi.org/10.3390/nu18050872
Vancouver
Wang H, Liu H, Wang M, Chi T, Liu F, Qu X, et al. Integrated Proteomics and Metabolomics Reveal the Direct Hepatic Protection of Propionate Against Alcoholic Liver Disease via the RGN-PPARα Pathway. Nutrients. 2026;18(5):872. doi:10.3390/nu18050872
BibTeX
@article{Wang2026,
author = {Wang, Haidi and Liu, Haitao and Wang, Miaoxin and Chi, Tengjiao and Liu, Fengting and Qu, Xinyan and Mu, Yan and Xu, Qi and Wang, Quanbo},
title = {Integrated Proteomics and Metabolomics Reveal the Direct Hepatic Protection of Propionate Against Alcoholic Liver Disease via the RGN-PPARα Pathway},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {5},
pages = {872},
doi = {10.3390/nu18050872}
}
EUVIMED